Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS scoreJoerg Hasford, Rüdiger Hehlmann, Michele Baccarani et al.|Blood|2011Cited by 497
Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trialR. Robert, Didier Payen, Joëlle Guilhot et al.|Intensive Care Medicine|2015Cited by 400
Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid LeukemiaClaude Preudhomme, François Guilhot, Éric Jourdan et al.|New England Journal of Medicine|2010Cited by 385
Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic respondersFrancesca Bonifazi, Michele Baccarani, Antonio De Vivo et al.|Blood|2001Cited by 319
Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemiaMarkus Pfirrmann, Bengt Simonsson, Michele Baccarani et al.|Leukemia|2015Cited by 298